Boardroom Alpha
10-Q primary document
ICCC · Quarterly Report (Form 10-Q) · Filed August 13, 2026

Immucell Corp10-Q exhibit

ex_1002091.htm
HTML Editor

Exhibit 3.1

 

  Delaware Page 1
  The First State  

 

 

 

 

I, CHARUNI PATIBANDA-SANCHEZ, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE OF AMENDMENT OF IMMUCELL CORPORATION, FILED IN THIS OFFICE ON THE SIXTEENTH DAY OF JUNE, A.D. 2026, AT 11:04 O`CLOCK A.M.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
z02.jpg
z01.jpg
 

 

2117088 8100 Authentication: 204256187
SR# 20263415963 Date: 06-17-26
You may verify this certificate online at corp.delaware.gov/authver.shtml  

                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

 

 

 

Docusign Envelope ID: EB860O81-9ED6-8117-82AD-3464C129D489

 

CERTIFICATE OF AMENDMENT

OF

CERTIFICATE OF INCORPORATION

OF

IMMUCELL CORPORATION

 

IMMUCELL CORPORATION, a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, hereby certifies as follows:

 

1.         The name of the Corporation is IMMUCELL CORPORATION.

 

2.         The Certificate of Incorporation of the Corporation is hereby amended by changing Article Eighth thereof so that, as amended, said Article shall be and read as follows:

 

"EIGHTH: A director or officer of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or officer except for liability (i) for any breach of the director's or officer's duty ofloyalty to the Corporation or its stockholders, (ii) for acts or omissions not in good faith or which involved intentional misconduct or a knowing violation oflaw,(iii) under Section 174 of the Delaware General Corporation Law, in the case of directors only, (iv) for any transaction from which the director or officer derived an improper personal benefit, or (v) for any action by or in the right of the Corporation, in the case of officers only.

 

If the Delaware General Corporation Law is hereafter amended to authorize the further elimination or limitation of the liability of directors or otlicers, then the liability of a director or otlicer of the Corporation shall be eliminated or limited to the fullest extent permitted by the Delaware General Corporation Law, as so amended.

 

Any repeal or modification of the foregoing provisions of this Article Eighth by the stockholders of the Corporation shall not adversely affect any right or protection of a director or officer of the Corporation existing at the time of such repeal or modification."

 

3.         The foregoing amendment shall be effective upon the filing of this Certificate of Amendment to the Certificate of Incorporation of the Corporation with the Secretary of State of the State of Delaware.

 

IN WITNESS WHEREOF, ImmuCell Corporation has caused this Certificate of Amendment to be signed by its duly authorized officer on this 15th day of June of 2026.

 

IMMUCELL CORPORATION

 

tim.jpg

 

 

 

 

 

State of Delaware

Secretary of State

Division of Corporations

Delivered 11:04 AM 06/16/2026

FILED 11:04 AM 06/16/2026

SR 20263415963 - File Number 2117088

 
 
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer